Life Sciences 1993-01-01

Geranylgeranylacetone protects the heart via caveolae and caveolin-3

Yasuo M. Tsutsumi, Rie Tsutsumi, Yousuke T. Horikawa, Yoko Sakai, Eisuke Hamaguchi, Yoshihiro Ishikawa, Utako Yokoyama, Asuka Kasai, Noriko Kambe, Katsuya Tanaka

Index: Life Sci. 101(1-2) , 43-8, (2014)

Full Text: HTML

Abstract

Aims Geranylgeranylacetone (GGA) is commonly utilized to protect the gastric mucosa in peptic ulcer disease. Recently GGA has been shown to protect the myocardium from ischemia/reperfusion by activating heat shock proteins. However, the exact mechanism as to how GGA activates these protective proteins is unknown. Caveolae and caveolin-3 (Cav-3) have been implicated in ischemia, anesthetic, and opioid induced cardiac protection. Given the lipophilic nature of GGA it is our hypothesis that GGA induced cardiac protection requires caveolae and Cav-3.

Related Compounds

Related Articles:

Heat shock protein 72 suppresses apoptosis by increasing the stability of X-linked inhibitor of apoptosis protein in renal ischemia/reperfusion injury.

2015-03-01

[Mol. Med. Report. 11(3) , 1793-9, (2014)]

Aldioxa improves delayed gastric emptying and impaired gastric compliance, pathophysiologic mechanisms of functional dyspepsia.

2015-01-01

[Sci. Rep. 5 , 17519, (2015)]

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

2012-01-01

[BMC Gastroenterol. 12 , 42, (2012)]

Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys.

2011-05-01

[Am. J. Physiol. Endocrinol. Metab. 300(5) , E894-901, (2011)]

Isoprenoid geranylgeranylacetone inhibits human colon cancer cells through induction of apoptosis and cell cycle arrest.

2010-10-01

[Anticancer Drugs 21(9) , 850-60, (2010)]

More Articles...